A point-based system to determine authorship eligibility in a large clinical trial: Insights from the ISCHEMIA trial’s authorship nomination system
ISCHEMIA employed a point-based authorship eligibility system that most authors found objective, merit-based, transparent, and equitable. Implementation of such a system should be considered for team science publications.
Authors
- David J. Maron (ORCID: https://orcid.org/0000-0002-4867-8588)
- Shari Esquenazi-Karonika (ORCID: https://orcid.org/0000-0002-2040-0250)
- Judith S. Hochman (ORCID: https://orcid.org/0000-0002-5889-5981)
- Patenne D. Mathews (ORCID: https://orcid.org/0000-0002-7028-1878)
- Mark Xavier
- Sean M. O’Brien
- Jerome L. Fleg
- Stavroula Boumakis
- June Lyo
- Anna Naumova
Institutions
- Autodesk (United States) (US)
- Clinical Research Institute (US)
- National Heart, Lung, and Blood Institute (US)
- New York University (US)
- Stanford University (US)
Publication Details
- Journal
- Journal of Clinical and Translational Science
- Published
- 2025-12-26
- DOI
- https://doi.org/10.1017/cts.2025.10214
- Primary Topic
- Sex and Gender in Healthcare
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- University of Cambridge